A METHOD OF TREATING PATIENTS WITH PULMONARY TUBERCULOSIS WITH ENHANCED RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS TO ANTI-TB DRUGS DURING THE INTENSIVE PHASE OF CHEMOTHERAPY

摘要

A method of treating patients with pulmonary tuberculosis with enhanced resistance of Mycobacterium tuberculosis to anti-TB drugs during the intensive phase of chemotherapy involves daily use of mean daily doses at one 5-effective anti-TB drugs and II series and linezolid at a dose of 600 mg 1 time per day orally. Assign step linezolid therapy, namely from the beginning of the intensive phase of chemotherapy to the bacterial suspension by smear microscopy - a dose of 600 mg 2 times a day intravenously, and after the suspension of bacteria and the completion of the intensive phase of chemotherapy - orally.